Top Picks

Now that Xencor Inc’s volume has hit 0.56 million, investors get a glimpse of its size.
On Tuesday, Xencor Inc (NASDAQ: XNCR) was -3.15% drop from the session before settling in for the closing price of ...

Microvision Inc (MVIS) volume exceeds 6.25 million: A new investment opportunity for investors
A new trading day began on Monday, with Microvision Inc (NASDAQ: MVIS) stock price down -7.63% from the previous day ...

Abercrombie & Fitch Co (ANF)’s latest performance is not what we had anticipated
On Monday, Abercrombie & Fitch Co (NYSE: ANF) opened higher 4.12% from the last session, before settling in for the ...

No matter how cynical the overall market is American Eagle Outfitters Inc (AEO) performance over the last week is recorded 14.56%
On Monday, American Eagle Outfitters Inc (NYSE: AEO) was 4.17% up from the session before settling in for the closing ...

Venture Global Inc (VG) is ready for next Episode as it posted an annual sales of 4,972 M
Venture Global Inc (NYSE: VG) kicked off on Monday, down -7.77% from the previous trading day, before settling in for ...

Draganfly Inc (DPRO) is destined for greater heights as its last quarter sales were 1,570 K
Draganfly Inc (NASDAQ: DPRO) on Monday, plunged -6.16% from the previous trading day, before settling in for the closing price ...

7.33% volatility in nLIGHT Inc (LASR) last month: This is a red flag warning
A new trading day began on Monday, with nLIGHT Inc (NASDAQ: LASR) stock price down -6.19% from the previous day ...

Now that Ventyx Biosciences Inc’s volume has hit 1.12 million, investors get a glimpse of its size.
On Monday, Ventyx Biosciences Inc (NASDAQ: VTYX) opened lower -6.20% from the last session, before settling in for the closing ...

United Natural Foods Inc (UNFI) volume exceeds 2.04 million: A new investment opportunity for investors
On Monday, United Natural Foods Inc (NYSE: UNFI) was -7.91% drop from the session before settling in for the closing ...

Nektar Therapeutics (NKTR)’s latest performance is not what we had anticipated
Nektar Therapeutics (NASDAQ: NKTR) kicked off on Monday, down -6.29% from the previous trading day, before settling in for the ...





